Identification of the prognostic and immunological roles of aquaporin 4: A potential target for survival and immunotherapy in glioma patients

Recent studies have revealed the critical role of AQP4 in the occurrence and development of gliomas. However, the role of AQP4 in immune regulation has not yet been reported. Many recent reports have identified the lymphatic system’s occurrence within the central nervous system (CNS) and the vital role of immune regulation in treating brain tumors. Therefore, the present study aimed to explore the role of AQP4 in the immune regulation of glioma. We used bioinformatics analysis to investigate the immunoregulatory function of AQP4, including its correlation with immunity, anti-tumor immune processes, immunotherapy, immune infiltration, tumor mutational burden (TMB), stemness, mutation, and pan-cancer. The results revealed that AQP4 was significantly associated with the expression of multiple immune checkpoints, immune cells, as well as multiple immune cell effector genes, and antigen presentation and processing abilities. Although no significant correlation was found between the AQP4 gene and IDH mutation and MGMT, AQP4 demonstrated substantial expression differences in different immunophenotypes and molecular types. Using the TTD database, we discovered that EGFR, ABAT, and PDGFRA are strongly associated with AQP4 expression in the glioblastoma (GBM) classification, and these factors could be the potential AQP4-related immunotherapy targets. Afterward, we screened the differential genes in the high and low AQP4 gene expression group, the high and low immune score group, and the high and low matrix score group and took the intersection as the candidate factor. Finally, univariate Cox analysis was used to find eight prognostic variables with significant differences across the candidate genes. After lasso dimensionality reduction, three genes built the model (RARRES1, SOCS3, and TTYH1). The scoring model generated by the three genes was eventually obtained after the multi-factor screening of the three genes. Finally, combined with clinical information and cox regression analysis, it was further confirmed that the model score could be used as an independent prognostic factor.

[1]  Jianmin Zhang,et al.  Update on the current knowledge of lymphatic drainage system and its emerging roles in glioma management , 2022, Immunology.

[2]  M. Aschner,et al.  The role of aquaporin 4 in brain tumors: implications for pathophysiology, diagnosis and therapy , 2022, Molecular Biology Reports.

[3]  C. Horbinski,et al.  Major Features of the 2021 WHO Classification of CNS Tumors , 2022, Neurotherapeutics.

[4]  D. Altmann,et al.  Meningeal lymphatic vessels mediate neurotropic viral drainage from the central nervous system , 2022, Nature Neuroscience.

[5]  M. Trojano,et al.  Alteration of the translational readthrough isoform AQP4ex induces redistribution and downregulation of AQP4 in human glioblastoma , 2022, Cellular and Molecular Life Sciences.

[6]  Yu-Long Lan,et al.  A Bioinformatics Analysis of the Potential Roles of Aquaporin 4 in Human Brain Tumors: An Immune-Related Process , 2021, Frontiers in Pharmacology.

[7]  E. Rudolf,et al.  Biology of Glioblastoma Multiforme—Exploration of Mitotic Catastrophe as a Potential Treatment Modality , 2020, International journal of molecular sciences.

[8]  Yuanting Zheng,et al.  Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway , 2020, Signal Transduction and Targeted Therapy.

[9]  Shuiyu Chen,et al.  Inhibition of lncRNA LINC00461/miR-216a/aquaporin 4 pathway suppresses cell proliferation, migration, invasion, and chemoresistance in glioma , 2020, Open life sciences.

[10]  B. Zhang,et al.  Gamabufotalin induces a negative feedback loop connecting ATP1A3 expression and the AQP4 pathway to promote temozolomide sensitivity in glioblastoma cells by targeting the amino acid Thr794 , 2019, Cell proliferation.

[11]  M. Amiry-Moghaddam.  AQP4 and the Fate of Gliomas. , 2019, Cancer research.

[12]  A. Vescovi,et al.  AQP4 Aggregation State Is a Determinant for Glioma Cell Fate. , 2019, Cancer research.

[13]  M. Trojano,et al.  AQP4ex is crucial for the anchoring of AQP4 at the astrocyte end-feet and for neuromyelitis optica antibody binding , 2019, Acta Neuropathologica Communications.

[14]  S. Mader,et al.  Aquaporin-4 Water Channel in the Brain and Its Implication for Health and Disease , 2019, Cells.

[15]  D. Binder,et al.  The role of aquaporin-4 in synaptic plasticity, memory and disease , 2018, Brain Research Bulletin.

[16]  R. Jiang,et al.  Down‐Regulation of AQP4 Expression via p38 MAPK Signaling in Temozolomide‐Induced Glioma Cells Growth Inhibition and Invasion Impairment , 2017, Journal of cellular biochemistry.

[17]  Xiaochi Ma,et al.  The potential roles of aquaporin 4 in malignant gliomas , 2017, Oncotarget.

[18]  Z. Fei,et al.  High expression of MMP9 in glioma affects cell proliferation and is associated with patient survival rates. , 2017, Oncology letters.

[19]  I. Mellman,et al.  Elements of cancer immunity and the cancer–immune set point , 2017, Nature.

[20]  R. Ritz,et al.  Is Upregulation of Aquaporin 4-M1 Isoform Responsible for the Loss of Typical Orthogonal Arrays of Particles in Astrocytomas? , 2016, International journal of molecular sciences.

[21]  Alex J. Smith,et al.  Superresolution Imaging of Aquaporin-4 Cluster Size in Antibody-Stained Paraffin Brain Sections. , 2015, Biophysical journal.

[22]  M. Papadopoulos,et al.  Key roles of aquaporins in tumor biology. , 2015, Biochimica et biophysica acta.

[23]  D. Basco,et al.  A novel human aquaporin-4 splice variant exhibits a dominant-negative activity: a new mechanism to regulate water permeability , 2014, Molecular biology of the cell.

[24]  E. Nagelhus,et al.  Physiological roles of aquaporin-4 in brain. , 2013, Physiological reviews.

[25]  G. Nikkhah,et al.  Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. , 2013, Cancer letters.

[26]  S. Zhang,et al.  Aquaporin-4 upregulated expression in glioma tissue is a reaction to glioma-associated edema induced by vascular endothelial growth factor. , 2012, Oncology reports.

[27]  Guilin Li,et al.  Differential expression of MMP-9 and AQP4 in human glioma samples. , 2012, Folia neuropathologica.

[28]  M. Papadopoulos,et al.  Aquaporin 4 and neuromyelitis optica , 2012, The Lancet Neurology.

[29]  A. Frigeri,et al.  Translational regulation mechanisms of aquaporin‐4 supramolecular organization in astrocytes , 2011, Glia.

[30]  A. Verkman,et al.  Model of aquaporin-4 supramolecular assembly in orthogonal arrays based on heterotetrameric association of M1-M23 isoforms. , 2011, Biophysical journal.

[31]  G. Hu,et al.  Novel role of aquaporin‐4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson’s disease , 2011, Aging cell.

[32]  Liangchen Fu,et al.  Aquaporin-4 in glioma invasion and an analysis of molecular mechanisms , 2010, Journal of Clinical Neuroscience.

[33]  A. Frigeri,et al.  Aquaporins as targets for drug discovery. , 2007, Current pharmaceutical design.

[34]  A. Warth,et al.  Expression pattern of the water channel aquaporin‐4 in human gliomas is associated with blood–brain barrier disturbance but not with patient survival , 2007, Journal of neuroscience research.